entertainment -WSS

entertainment

author：leisure time 2025-10-01 04:11:00 - browse：53589

Crowd of people in the formation of a dollar sign -- health policy coverage from STAT — The finance chief of the country’s largest private psychiatric hospital operator, UHS, made a blunt statement today: The company admits patients based on whose insurance pays more. Adobe

The country’s largest private psychiatric hospital operator cherry-picks patients whose insurance will pay more, its finance chief said on an earnings call Wednesday.

It’s no secret that such hospitals, especially when run by for-profit companies, base admission decisions on how much they’ll get paid, but it’s rare to hear the practice described so bluntly. The comments came from Steve Filton, the chief financial officer of investor-owned Universal Health Services, a company that runs more than 300 behavioral health hospitals nationwide that handled just shy of 120,000 admissions in the three months that ended June 30.

UHS has been “simply admitting patients whose insurance will pay us more,” Filton said on the company’s second quarter earnings call. “In an environment where we can only treat a limited number of patients, we can be more selective about who we treat and the fairness of what we think we’re being paid.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Medicare innovation center doesn’t save money, experts say

WSS

Health insurers' Q3 question: how much care are people getting?

The stability of $0 premiums in Medicare Advantage

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

CDC picks Alphabet's Verily for wasterwater surveillance contract

IRA could hurt research into orphan drugs for rare diseases

Health insurers' Q3 question: how much care are people getting?

hotspot

entertainment

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Setback for rare diseases as Taysha Gene Therapies pulls back

Drug repurposing or repositioning? The language matters

Stop Congress from blocking public access to science

State Dept. review finds Biden bears some blame for Afghanistan failures

Study points to new risk in gene therapy death of Terry Horgan

Anesthesiologist group: stop taking Ozempic before surgery

Experts study whether long Covid risk adds up with each reinfection

ChatGPT in medicine: STAT answers readers' burning questions

Telehealth for opioid use disorder is lifesaving

knowledge

Stop Congress from blocking public access to science

Popular nasal decongestant doesn't actually relieve congestion

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Congress extends some pandemic preparedness programs

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Generate Biomedicines machine learning biotech raises $273M

hotspot

entertainment

hotspot

hotspot